Anzahl der Publikationen: 4
	Zeitschriftenartikel
    Jodeleit, Henrika; Winkelmann, Paula; Caesar, Janina; Sterz, Sebastian; Holdt, Lesca M.; Beigel, Florian; Stallhofer, Johannes; Breiteneicher, Simone; Bartnik, Eckart; Leeuw, Thomas; Siebeck, Matthias  ORCID: https://orcid.org/0000-0001-5290-5344 und Gropp, Roswitha
ORCID: https://orcid.org/0000-0001-5290-5344 und Gropp, Roswitha  ORCID: https://orcid.org/0000-0003-4756-261X
  
(2021):
		Head-to-head study of oxelumab and adalimumab in a mouse model of ulcerative colitis based on NOD/Scid IL2Rγnull mice reconstituted with human peripheral blood mononuclear cells.
	
	 In: Disease Models & Mechanisms, Bd. 14, Nr.  1, dmm046995
      
        
          
             [PDF, 3MB]
ORCID: https://orcid.org/0000-0003-4756-261X
  
(2021):
		Head-to-head study of oxelumab and adalimumab in a mouse model of ulcerative colitis based on NOD/Scid IL2Rγnull mice reconstituted with human peripheral blood mononuclear cells.
	
	 In: Disease Models & Mechanisms, Bd. 14, Nr.  1, dmm046995
      
        
          
             [PDF, 3MB]
          
        
      
 
    Jodeleit, Henrika; Winkelmann, Paula; Caesar, Janina; Sterz, Sebastian; Holdt, Lesca M.; Beigel, Florian; Stallhofer, Johannes; Breiteneicher, Simone; Bartnik, Eckart; Leeuw, Thomas; Siebeck, Matthias und Gropp, Roswitha
  
(2021):
		Head-to-head study of oxelumab and adalimumab in a mouse reconstituted with human peripheral blood mononuclear cells.
	
	 In: Disease Models & Mechanisms, Bd. 14, Nr.  1
      
        
      
 
    Jodeleit, Henrika; Caesar, Janina; Aguilera, Christina Villarroel; Sterz, Sebastian; Holdt, Lesca; Beigel, Florian; Stallhofer, Johannes; Breiteneicher, Simone; Bartnik, Eckart; Siebeck, Matthias und Gropp, Roswitha
  
(2020):
		The Combination of Patient Profiling and Preclinical Studies in a Mouse Model Based on NOD/Scid IL2R gamma(null) Mice Reconstituted With Peripheral Blood Mononuclear Cells From Patients With Ulcerative Colitis May Lead to Stratification of Patients for Treatment With Adalimumab.
	
	 In: Inflammatory Bowel Diseases, Bd. 26, Nr.  4: S. 557-569
	
      
        
      
 
		Diese Liste wurde am 
				Sun Oct 26 02:53:14 2025 CEST
			 erstellt.